New treatment study for enlarged prostate (BPH)
Treatments studied
Part of Kidney & urinary clinical trials.
This trial tests new treatment strategies for benign prostatic hyperplasia (BPH, an enlarged prostate) using a special MRI scan and a medication called finasteride. It aims to find better ways to manage symptoms and identify markers that predict response.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- Your doctor has recommended finasteride for your BPH.
- Your PSA level was below 20 ng/mL in the last 6 months.
- You are willing to stay on your current medications for urinary symptoms.
- You have not had blood clots (like DVT or pulmonary embolism) before.
- You have never been diagnosed with prostate cancer or precancerous changes.
- You have not had radiation to your pelvis.
- You are not currently being treated for bladder cancer with medications placed into the bladder.
- You have not taken medications like azacitidine, decitabine, or hydralazine.
- You are not taking warfarin (a blood thinner).
- You have not taken finasteride or dutasteride in the last year.
- You have not been diagnosed with diabetes.
- You have not been diagnosed with a neurodegenerative disease (like Parkinson's or Alzheimer's).
- You have no history of allergy to IV iron supplements.
- You are not taking cholestyramine (a cholesterol-lowering drug).
- You can have an MRI without metal implants, pacemaker, or severe claustrophobia.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a prostate test marker to understand who is more likely to benefit from 5-ARI medicines such as finasteride or dutasteride. If you have enlarged prostate symptoms and are getting a biopsy, the results may help doctors better choose or interpret 5-ARI treatment.
This trial tests a new device designed to treat symptoms of an enlarged prostate (BPH), such as frequent or difficult urination. It may help improve urine flow and reduce discomfort without traditional surgery.
This trial tests whether combining two medicines works better than one alone for easing urinary symptoms caused by an enlarged prostate. If you have bothersome symptoms and a larger prostate, this study may help you find a more effective treatment.
This study tests a new medication (called DNN.65.21.005) for men with an enlarged prostate (also called benign prostatic hyperplasia, or BPH) who have bothersome urinary symptoms. The goal is to see if this medication safely relieves symptoms like frequent or difficult urination.
This study compares a new once-daily pill to an existing medication for men with an enlarged prostate. It aims to see if the new pill is better at improving urinary symptoms and urine flow.
This trial tests whether a drug called adalimumab (a TNF blocker) can improve symptoms of an enlarged prostate. It is for men aged 45-80 with a large prostate and bothersome urinary symptoms who have not used this type of medication before.
Hear when a new Lower Urinary Track Symptoms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.